IBL C1Q-CIC CIA TEST

IBL C1Q-CIC CIA TEST is an FDA 510(k)-cleared medical device (K032254) manufactured by Ibl GmbH. This device is classified under the Immunology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on August 28, 2003. Regulation: 8.